Congenital cystic adenomatoid malformation of the lung insights into the pathogenesis utilizing quantitative analysis of vascular marker CD34 (QBEND-10) and cell proliferation marker MIB-1

J. Cangiarella, M. Alba Greco, Frederic B Askin, E. Perlman, S. Goswami, J. Jagirdar

Research output: Contribution to journalArticle

Abstract

Congenital cystic adenomatoid malformation (CCAM) encompasses a spectrum of variably cystic developmental anomalies of the lung histologically characterized by immature lung tissue. The pathogenesis is uncertain, but many investigators favor a maturation arrest in bronchopulmonary development. To investigate this hypothesis, the vascular development and proliferation capacity of lung tissue with CCAM type I from nine infants ranging in age from 20 weeks gestation to 42 days old were studied immunohistochemically utilizing CD34 for the former and MIB-1 for the latter. Both markers were quantitated on an image analysis system. CCAM was hypovascular with a mean vascular index of 20.05% ± 6.58 compared to 40.06% ± 4.19 for the age-matched controls (P <0.000001). The proliferation index of both epithelial and mesenchymal components was higher in CCAM (10.46 ± 3.48) than in control tissue (7.14 ± 1.88; P <0.012). In contrast to the control lung tissue which showed a remarkable synchrony between the vascular development and proliferation throughout the parenchyma, focal asynchrony between the proliferation of the epithelial and stromal components was noted in CCAM. The vascularity in CCAM corresponds to that seen in early gestation. The cellular proliferation in CCAM is higher than in full-term infants and corresponds to late second trimester or early third trimester fetuses. These findings support the proposed pathogenesis of a maturation defect in lung embryogenesis.

Original languageEnglish (US)
Pages (from-to)913-918
Number of pages6
JournalModern Pathology
Volume8
Issue number9
StatePublished - 1995
Externally publishedYes

Fingerprint

Congenital Cystic Adenomatoid Malformation of Lung
Blood Vessels
Cell Proliferation
Lung
Lung Volume Measurements
Pregnancy
Third Pregnancy Trimester
Second Pregnancy Trimester
Embryonic Development
Fetus
Research Personnel

Keywords

  • CD34
  • cystic adenomatoid malformation
  • lungs
  • MIB-1
  • pathogenesis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Congenital cystic adenomatoid malformation of the lung insights into the pathogenesis utilizing quantitative analysis of vascular marker CD34 (QBEND-10) and cell proliferation marker MIB-1. / Cangiarella, J.; Alba Greco, M.; Askin, Frederic B; Perlman, E.; Goswami, S.; Jagirdar, J.

In: Modern Pathology, Vol. 8, No. 9, 1995, p. 913-918.

Research output: Contribution to journalArticle

@article{ece8d968d6f74159873840d4522e6379,
title = "Congenital cystic adenomatoid malformation of the lung insights into the pathogenesis utilizing quantitative analysis of vascular marker CD34 (QBEND-10) and cell proliferation marker MIB-1",
abstract = "Congenital cystic adenomatoid malformation (CCAM) encompasses a spectrum of variably cystic developmental anomalies of the lung histologically characterized by immature lung tissue. The pathogenesis is uncertain, but many investigators favor a maturation arrest in bronchopulmonary development. To investigate this hypothesis, the vascular development and proliferation capacity of lung tissue with CCAM type I from nine infants ranging in age from 20 weeks gestation to 42 days old were studied immunohistochemically utilizing CD34 for the former and MIB-1 for the latter. Both markers were quantitated on an image analysis system. CCAM was hypovascular with a mean vascular index of 20.05{\%} ± 6.58 compared to 40.06{\%} ± 4.19 for the age-matched controls (P <0.000001). The proliferation index of both epithelial and mesenchymal components was higher in CCAM (10.46 ± 3.48) than in control tissue (7.14 ± 1.88; P <0.012). In contrast to the control lung tissue which showed a remarkable synchrony between the vascular development and proliferation throughout the parenchyma, focal asynchrony between the proliferation of the epithelial and stromal components was noted in CCAM. The vascularity in CCAM corresponds to that seen in early gestation. The cellular proliferation in CCAM is higher than in full-term infants and corresponds to late second trimester or early third trimester fetuses. These findings support the proposed pathogenesis of a maturation defect in lung embryogenesis.",
keywords = "CD34, cystic adenomatoid malformation, lungs, MIB-1, pathogenesis",
author = "J. Cangiarella and {Alba Greco}, M. and Askin, {Frederic B} and E. Perlman and S. Goswami and J. Jagirdar",
year = "1995",
language = "English (US)",
volume = "8",
pages = "913--918",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Congenital cystic adenomatoid malformation of the lung insights into the pathogenesis utilizing quantitative analysis of vascular marker CD34 (QBEND-10) and cell proliferation marker MIB-1

AU - Cangiarella, J.

AU - Alba Greco, M.

AU - Askin, Frederic B

AU - Perlman, E.

AU - Goswami, S.

AU - Jagirdar, J.

PY - 1995

Y1 - 1995

N2 - Congenital cystic adenomatoid malformation (CCAM) encompasses a spectrum of variably cystic developmental anomalies of the lung histologically characterized by immature lung tissue. The pathogenesis is uncertain, but many investigators favor a maturation arrest in bronchopulmonary development. To investigate this hypothesis, the vascular development and proliferation capacity of lung tissue with CCAM type I from nine infants ranging in age from 20 weeks gestation to 42 days old were studied immunohistochemically utilizing CD34 for the former and MIB-1 for the latter. Both markers were quantitated on an image analysis system. CCAM was hypovascular with a mean vascular index of 20.05% ± 6.58 compared to 40.06% ± 4.19 for the age-matched controls (P <0.000001). The proliferation index of both epithelial and mesenchymal components was higher in CCAM (10.46 ± 3.48) than in control tissue (7.14 ± 1.88; P <0.012). In contrast to the control lung tissue which showed a remarkable synchrony between the vascular development and proliferation throughout the parenchyma, focal asynchrony between the proliferation of the epithelial and stromal components was noted in CCAM. The vascularity in CCAM corresponds to that seen in early gestation. The cellular proliferation in CCAM is higher than in full-term infants and corresponds to late second trimester or early third trimester fetuses. These findings support the proposed pathogenesis of a maturation defect in lung embryogenesis.

AB - Congenital cystic adenomatoid malformation (CCAM) encompasses a spectrum of variably cystic developmental anomalies of the lung histologically characterized by immature lung tissue. The pathogenesis is uncertain, but many investigators favor a maturation arrest in bronchopulmonary development. To investigate this hypothesis, the vascular development and proliferation capacity of lung tissue with CCAM type I from nine infants ranging in age from 20 weeks gestation to 42 days old were studied immunohistochemically utilizing CD34 for the former and MIB-1 for the latter. Both markers were quantitated on an image analysis system. CCAM was hypovascular with a mean vascular index of 20.05% ± 6.58 compared to 40.06% ± 4.19 for the age-matched controls (P <0.000001). The proliferation index of both epithelial and mesenchymal components was higher in CCAM (10.46 ± 3.48) than in control tissue (7.14 ± 1.88; P <0.012). In contrast to the control lung tissue which showed a remarkable synchrony between the vascular development and proliferation throughout the parenchyma, focal asynchrony between the proliferation of the epithelial and stromal components was noted in CCAM. The vascularity in CCAM corresponds to that seen in early gestation. The cellular proliferation in CCAM is higher than in full-term infants and corresponds to late second trimester or early third trimester fetuses. These findings support the proposed pathogenesis of a maturation defect in lung embryogenesis.

KW - CD34

KW - cystic adenomatoid malformation

KW - lungs

KW - MIB-1

KW - pathogenesis

UR - http://www.scopus.com/inward/record.url?scp=0029558416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029558416&partnerID=8YFLogxK

M3 - Article

C2 - 8751331

AN - SCOPUS:0029558416

VL - 8

SP - 913

EP - 918

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 9

ER -